Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | KMDA |
---|---|---|
09:32 ET | 260 | 5.85 |
09:34 ET | 300 | 5.8 |
09:36 ET | 2950 | 5.82 |
09:48 ET | 500 | 5.7974 |
09:54 ET | 198 | 5.79 |
09:57 ET | 100 | 5.76 |
10:08 ET | 100 | 5.7899 |
10:10 ET | 100 | 5.7899 |
10:15 ET | 100 | 5.7415 |
10:19 ET | 100 | 5.74 |
10:24 ET | 100 | 5.74 |
10:39 ET | 100 | 5.73 |
10:44 ET | 100 | 5.736 |
10:51 ET | 100 | 5.74 |
10:57 ET | 100 | 5.72 |
11:36 ET | 100 | 5.735 |
11:38 ET | 200 | 5.7235 |
11:51 ET | 460 | 5.75 |
11:58 ET | 100 | 5.75 |
12:05 ET | 1852 | 5.76 |
12:07 ET | 100 | 5.76 |
12:09 ET | 100 | 5.74 |
12:20 ET | 100 | 5.745 |
12:39 ET | 1000 | 5.745 |
12:50 ET | 100 | 5.745 |
12:54 ET | 200 | 5.75 |
12:56 ET | 300 | 5.75 |
01:10 ET | 100 | 5.755 |
01:39 ET | 433 | 5.74 |
01:51 ET | 100 | 5.75 |
02:02 ET | 1300 | 5.78 |
02:04 ET | 100 | 5.78 |
02:18 ET | 100 | 5.77 |
02:20 ET | 100 | 5.77 |
02:24 ET | 100 | 5.77 |
02:29 ET | 100 | 5.76 |
03:00 ET | 100 | 5.76 |
03:23 ET | 3000 | 5.78 |
03:39 ET | 5073 | 5.74 |
03:41 ET | 100 | 5.73 |
03:50 ET | 1900 | 5.735 |
03:56 ET | 100 | 5.73 |
03:59 ET | 1003 | 5.74 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Kamada Ltd | 329.9M | 32.7x | -22.48% |
Sutro Biopharma Inc | 350.0M | -2.4x | --- |
Agenus Inc | 240.9M | -0.9x | --- |
Travere Therapeutics Inc | 519.1M | -1.3x | --- |
Heron Therapeutics Inc | 453.4M | -3.5x | --- |
Entrada Therapeutics Inc | 473.2M | 22.4x | --- |
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $329.9M |
---|---|
Revenue (TTM) | $142.5M |
Shares Outstanding | 57.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.07 |
EPS | $0.18 |
Book Value | $4.25 |
P/E Ratio | 32.7x |
Price/Sales (TTM) | 2.3 |
Price/Cash Flow (TTM) | 15.7x |
Operating Margin | 7.06% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.